about
Determining seminal plasma human immunodeficiency virus type 1 load in the context of efficient highly active antiretroviral therapy.Patterns of residual HIV-1 RNA shedding in the seminal plasma of patients on effective antiretroviral therapy.Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer.Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.Trying to avoid the transmission of human immunodeficiency virus particles in sperm ejaculates.Impact of Hodgkin or non-Hodgkin lymphoma and their treatments on sperm aneuploidy: a prospective study by the French CECOS network.Good efficiency of intrauterine insemination programme for serodiscordant couples with HIV-1 infected male partner: a retrospective comparative study.Anti-sperm antibodies detection by a modified MAR test: Towards a better definition of its indicationsDecreased semen volume and spermatozoa motility in HIV-1-infected patients under antiretroviral treatmentEpitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteinsAzoospermic HIV-1 infected patients wishing to have children: proposed strategy to reduce HIV-1 transmission risk during sperm retrieval and intracytoplasmic sperm injection: Case ReportPersistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tractIn vitro assessment of the adverse effects of antiretroviral drugs on the human male gameteAntiviral effect of maraviroc in semen: a case reportDecrease of spermatozoa with an unbalanced chromosome content after cell sorting in men carrying a structural chromosomal abnormality
P50
Q37333675-D43177F0-8965-4E58-A681-F3C44FB20192Q40042087-8AA60194-678F-4022-A849-061CB980D6BBQ42410781-51F8FA90-6406-457D-83AD-4EE7BC3F821DQ44411224-C6A46E54-4D79-4726-88B0-215EA0F7809BQ45405673-8A888C98-3A77-40B1-9397-DF720E25D317Q47639443-2F72CC69-AF00-464E-B0C5-F43787B365EDQ51751323-A2BBD960-2460-4058-A69A-87AF0C13A60AQ58583339-265E9185-A81C-4FBE-81CA-51B4028288ECQ79535501-9EA33242-C179-47C5-9053-805B86B23C5DQ79895747-B05646AA-229C-41EE-A8D6-7630025DC5BFQ80641473-218DC737-263D-4970-BFA2-58A8B4D9FF2CQ81889926-3297291E-6BCB-483B-A1D1-2788780B059FQ82731262-5D50ECA0-0592-4E29-84C2-C05E39D39F0AQ83380850-7198AEE9-D978-4670-A9A5-009DEF591859Q92211378-B2D9C733-D731-4EB7-8F5C-3930EE354943
P50
description
investigador
@es
researcher
@en
name
Nathalie Moinard
@en
Nathalie Moinard
@nl
type
label
Nathalie Moinard
@en
Nathalie Moinard
@nl
prefLabel
Nathalie Moinard
@en
Nathalie Moinard
@nl
P31
P496
0000-0003-2127-0993